Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lifecell International Pvt. |
RCV003228760 | SCV003925470 | likely pathogenic | Peroxisome biogenesis disorder 7A (Zellweger) | criteria provided, single submitter | clinical testing | A Heterozygous indel variant c.379_380delinsGA in Exon 4 of the PEX26 gene that results in the amino acid substitution p.Leu127Glu was identified. The observed variant has a minimum allele frequency of 0% in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease- causing. Based on the above evidence this variant has been classified as Likely Pathogenic according to the ACMG guidelines. |